Zymeworks Inc. Common Shares (ZYME): Price and Financial Metrics
ZYME Price/Volume Stats
Current price | $12.37 | 52-week high | $17.70 |
Prev. close | $12.71 | 52-week low | $8.27 |
Day low | $12.36 | Volume | 301,400 |
Day high | $12.72 | Avg. volume | 548,988 |
50-day MA | $12.12 | Dividend yield | N/A |
200-day MA | $13.13 | Market Cap | 860.67M |
ZYME Stock Price Chart Interactive Chart >
Zymeworks Inc. Common Shares (ZYME) Company Bio
Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company was founded in 2003 and is based in Vancouver, BC.
ZYME Price Returns
1-mo | 10.15% |
3-mo | 0.00% |
6-mo | -14.69% |
1-year | 47.09% |
3-year | 120.11% |
5-year | -65.66% |
YTD | -15.51% |
2024 | 40.90% |
2023 | 32.19% |
2022 | -52.04% |
2021 | -65.32% |
2020 | 3.96% |
Continue Researching ZYME
Here are a few links from around the web to help you further your research on Zymeworks Inc's stock as an investment opportunity:Zymeworks Inc (ZYME) Stock Price | Nasdaq
Zymeworks Inc (ZYME) Stock Quote, History and News - Yahoo Finance
Zymeworks Inc (ZYME) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...